<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>Renal Protection on GLP-1 Guide — Ozempic, Wegovy, Mounjaro</title><link>https://glp1decode.com/tags/renal-protection/</link><description>Recent content in Renal Protection on GLP-1 Guide — Ozempic, Wegovy, Mounjaro</description><image><title>GLP-1 Guide — Ozempic, Wegovy, Mounjaro</title><url>https://glp1decode.com/images/default-og.png</url><link>https://glp1decode.com/images/default-og.png</link></image><generator>Hugo</generator><language>en</language><lastBuildDate>Fri, 19 Jun 2026 12:00:00 +0800</lastBuildDate><atom:link href="https://glp1decode.com/tags/renal-protection/index.xml" rel="self" type="application/rss+xml"/><item><title>Ozempic and kidney health: what the FLOW trial means for you</title><link>https://glp1decode.com/posts/ozempic-kidney-health-2026/</link><pubDate>Fri, 19 Jun 2026 12:00:00 +0800</pubDate><guid>https://glp1decode.com/posts/ozempic-kidney-health-2026/</guid><description>The FLOW trial showed that semaglutide protects kidneys in people with type 2 diabetes and chronic kidney disease. Here&amp;#39;s what the data means and who benefits most.</description></item></channel></rss>